Zhejiang CONBA Pharmaceutical Co.,Ltd.

600572.SS

600572.SSZhejiang CONBA Pharmaceutical Co.,Ltd. CN flag

Shanghai Stock Exchange

4.53

CNY

+0.02

(+0.44%)

0.23EPS

19.70P/E

11.42BMarket Cap

May 09Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE000001H86

Return %

Stock

S&P500

0.22

12.07

1.12

62.30

-24.75

98.08

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.52	1.43	1.73	2.29	2.46	2.08	2.67	2.55	2.35	2.54	2.35	2.62	2.62	2.52
Basic EPS, GAAP	0.16	0.2	0.27	0.19	0.18	0.28	0.31	-0.13	0.18	0.78	0.14	0.23	0.25	0.24
Free Cash Flow per Basic Share	- -	-0.12	0.09	0.23	0.3	0.17	0.06	0.25	0.31	0.12	0.34	0.27	0.29	-0.1
Dividend per Share	0.09	0.08	0.11	0.16	0.12	0.13	0.18	0.2	0.06	0.03	0.19	0.16	0.21	0.21
Book Value per Share	0.76	0.81	1	1.28	1.64	1.78	1.84	1.53	1.79	2.48	2.4	2.41	2.5	2.54
Tangible Book Value per Share	1.11	1.01	0.94	1.25	1.26	1.76	1.7	1.62	1.91	2.73	2.64	2.64	2.55	2.59
Basic Weighted Avg Shares	1,795	2,047	2,071	2,318	2,450	2,540	2,630	2,659	2,518	2,586	2,558	2,572	2,490	2,525
Sales/Revenue/Turnover	2,734	2,924	3,582	5,302	6,020	5,294	7,018	6,768	5,909	6,568	6,000	6,733	6,515	6,376
Operating Margin (%)	12.87	14.54	18.39	16.57	12.71	19.26	16.63	15.39	12.48	13.39	13.09	12.55	10.96	10.28
Depreciation Expense	88	100	128	174	230	217	241	261	266	287	277	324	345	- -
Net Income, GAAP	296	417	552	440	441	711	815	-346	453	2,017	358	592	622	596
Effective Tax Rate (%)	16.43	17.89	14.53	17.49	24.39	18.54	20.55	- -	28.27	15.48	22.02	12.11	15.59	15.51
Profit Margin (%)	10.82	14.27	15.42	8.31	7.33	13.43	11.62	-5.11	7.67	30.72	5.97	8.79	9.55	9.34
Working Capital	1,334	1,138	332	710	1,124	2,336	1,258	502	882	2,298	2,606	2,603	1,902	2,134
LT Debt	653	654	904	532	1,134	1,110	1,258	511	507	13	334	306	120	110
Total Equity	2,441	2,592	3,370	4,565	4,488	5,844	5,856	4,943	5,349	7,635	7,324	7,350	6,913	7,115
Return on Invested Capital (%)	9.13	9.24	12.62	11.83	8.52	11.75	11.51	- -	6.83	8.72	6.86	8.69	7.58	6.87
Return on Capital (%)	11.37	14.8	12.28	9.52	9.31	12.02	12.82	- -	6.28	25.24	3.66	7.06	8.45	7.99
Return on Common Equity (%)	22.77	27.58	29.62	17.49	12.63	16.68	17.43	-7.77	10.59	36.94	5.7	9.57	10.02	9.28

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	7.73%	-0.24%	-3.23%
Net Income, GAAP	1.54%	20.41%	5.21%
Free Cash Flow	55.1%	24.55%	4.7%
Total Cash Common Dividend	49.34%	74.83%	24.61%
Total Equity	8.99%	8.26%	-5.95%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Guoliang Luo
Full Time Employees: 8,411
Sector: Healthcare
Industry: Drug Manufacturers - General
Address: No. 568, Binkang Road Hangzhou People's Republic of China
IPO Date: Apr 12, 2004
Website: conbagroup.com
Similar Companies: Merck & Co., Inc. (6MK.DE)
CSPC Pharmaceutical Group Limited (CHJTF)
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CSPC Pharmaceutical Group Limited (1093.HK)
Marksans Pharma Limited (MARKSANS.NS)
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
Business: Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

	Sep'24	Dec'24	Mar'25
ST Debt	279	304	166
LT Borrowings	138	118	108
LT Finance Leases	5	2	2
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	2,570	2,583	2,584
Market Capitalization	12,655	11,986	11,313

	Sep'24	Dec'24	Mar'25
Total Current Assets	4,352	4,419	4,518
Accounts Receivable, Net	1,391	1,147	1,338
Cash, Cash Equivalents & STI	803	1,322	771
Inventories	1,315	1,266	1,202
Total Current Liabilities	2,458	2,516	2,384
Payables & Accruals	- -	- -	- -
ST Debt	279	304	166
Deferred Revenue	- -	- -	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.52	1.43	1.73	2.29	2.46	2.08	2.67	2.55	2.35	2.54	2.35	2.62	2.62	2.52
Basic EPS, GAAP	0.16	0.2	0.27	0.19	0.18	0.28	0.31	-0.13	0.18	0.78	0.14	0.23	0.25	0.24
Free Cash Flow per Basic Share	- -	-0.12	0.09	0.23	0.3	0.17	0.06	0.25	0.31	0.12	0.34	0.27	0.29	-0.1
Dividend per Share	0.09	0.08	0.11	0.16	0.12	0.13	0.18	0.2	0.06	0.03	0.19	0.16	0.21	0.21
Book Value per Share	0.76	0.81	1	1.28	1.64	1.78	1.84	1.53	1.79	2.48	2.4	2.41	2.5	2.54
Tangible Book Value per Share	1.11	1.01	0.94	1.25	1.26	1.76	1.7	1.62	1.91	2.73	2.64	2.64	2.55	2.59
Basic Weighted Avg Shares	1,795	2,047	2,071	2,318	2,450	2,540	2,630	2,659	2,518	2,586	2,558	2,572	2,490	2,525
Sales/Revenue/Turnover	2,734	2,924	3,582	5,302	6,020	5,294	7,018	6,768	5,909	6,568	6,000	6,733	6,515	6,376
Operating Margin (%)	12.87	14.54	18.39	16.57	12.71	19.26	16.63	15.39	12.48	13.39	13.09	12.55	10.96	10.28
Depreciation Expense	88	100	128	174	230	217	241	261	266	287	277	324	345	- -
Net Income, GAAP	296	417	552	440	441	711	815	-346	453	2,017	358	592	622	596
Effective Tax Rate (%)	16.43	17.89	14.53	17.49	24.39	18.54	20.55	- -	28.27	15.48	22.02	12.11	15.59	15.51
Profit Margin (%)	10.82	14.27	15.42	8.31	7.33	13.43	11.62	-5.11	7.67	30.72	5.97	8.79	9.55	9.34
Working Capital	1,334	1,138	332	710	1,124	2,336	1,258	502	882	2,298	2,606	2,603	1,902	2,134
LT Debt	653	654	904	532	1,134	1,110	1,258	511	507	13	334	306	120	110
Total Equity	2,441	2,592	3,370	4,565	4,488	5,844	5,856	4,943	5,349	7,635	7,324	7,350	6,913	7,115
Return on Invested Capital (%)	9.13	9.24	12.62	11.83	8.52	11.75	11.51	- -	6.83	8.72	6.86	8.69	7.58	6.87
Return on Capital (%)	11.37	14.8	12.28	9.52	9.31	12.02	12.82	- -	6.28	25.24	3.66	7.06	8.45	7.99
Return on Common Equity (%)	22.77	27.58	29.62	17.49	12.63	16.68	17.43	-7.77	10.59	36.94	5.7	9.57	10.02	9.28

Year	Q1	Q2	Q3	Q4	FY
2023	2,131	1,634	1,420	1,549	6,733
2024	1,824	1,624	1,465	1,602	6,515
2025	1,685	- -	- -	- -	- -

Zhejiang CONBA Pharmaceutical Co.,Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year